375 related articles for article (PubMed ID: 27020789)
1. Pharmacokinetics of linezolid in critically ill patients.
Sazdanovic P; Jankovic SM; Kostic M; Dimitrijevic A; Stefanovic S
Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):595-600. PubMed ID: 27020789
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and preliminary safety of high dose linezolid for the treatment of Gram-positive bacterial infections.
Lopez-Garcia B; Luque S; Roberts JA; Grau S
J Infect; 2015 Nov; 71(5):604-7. PubMed ID: 26099449
[No Abstract] [Full Text] [Related]
3. Pharmacokinetics of Linezolid Dose Adjustment for Creatinine Clearance in Critically Ill Patients: A Multicenter, Prospective, Open-Label, Observational Study.
Wang X; Wang Y; Yao F; Chen S; Hou Y; Zheng Z; Luo J; Qiu B; Li Z; Wang Y; Wu Z; Lan J; Chen C
Drug Des Devel Ther; 2021; 15():2129-2141. PubMed ID: 34040351
[TBL] [Abstract][Full Text] [Related]
4. Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections.
Luque S; Grau S; Alvarez-Lerma F; Ferrández O; Campillo N; Horcajada JP; Basas M; Lipman J; Roberts JA
Int J Antimicrob Agents; 2014 Nov; 44(5):409-15. PubMed ID: 25216547
[TBL] [Abstract][Full Text] [Related]
5. Impact of augmented renal clearance on the pharmacokinetics of linezolid: Advantages of continuous infusion from a pharmacokinetic/pharmacodynamic perspective.
Barrasa H; Soraluce A; Usón E; Sainz J; Martín A; Sánchez-Izquierdo JÁ; Maynar J; Rodríguez-Gascón A; Isla A
Int J Infect Dis; 2020 Apr; 93():329-338. PubMed ID: 32112965
[TBL] [Abstract][Full Text] [Related]
6. Linezolid extracorporeal removal during haemodialysis with high cut-off membrane in critically ill patients.
Villa G; Cassetta MI; Tofani L; Valente S; Chelazzi C; Falsini S; De Gaudio AR; Novelli A; Ronco C; Adembri C
Int J Antimicrob Agents; 2015 Oct; 46(4):465-8. PubMed ID: 26315198
[TBL] [Abstract][Full Text] [Related]
7. Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients.
Minichmayr IK; Schaeftlein A; Kuti JL; Zeitlinger M; Kloft C
Clin Pharmacokinet; 2017 Jun; 56(6):617-633. PubMed ID: 27753002
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic/pharmacodynamic evaluation of linezolid for the treatment of staphylococcal infections in critically ill patients.
Dong H; Xie J; Wang T; Chen L; Zeng X; Sun J; Wang X; Dong Y
Int J Antimicrob Agents; 2016 Sep; 48(3):259-64. PubMed ID: 27474469
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetic/pharmacodynamic profile of linezolid in severely ill intensive care unit patients.
Dong H; Wang X; Dong Y; Lei J; Li H; You H; Wang M; Xing J; Sun J; Zhu H
Int J Antimicrob Agents; 2011 Oct; 38(4):296-300. PubMed ID: 21741222
[TBL] [Abstract][Full Text] [Related]
10. Linezolid in liver failure: exploring the value of the maximal liver function capacity (LiMAx) test in a pharmacokinetic pilot study.
Wicha SG; Frey OR; Roehr AC; Pratschke J; Stockmann M; Alraish R; Wuensch T; Kaffarnik M
Int J Antimicrob Agents; 2017 Oct; 50(4):557-563. PubMed ID: 28711678
[TBL] [Abstract][Full Text] [Related]
11. Effects of continuous renal replacement therapy on linezolid pharmacokinetic/pharmacodynamics: a systematic review.
Villa G; Di Maggio P; De Gaudio AR; Novelli A; Antoniotti R; Fiaccadori E; Adembri C
Crit Care; 2016 Nov; 20(1):374. PubMed ID: 27863531
[TBL] [Abstract][Full Text] [Related]
12. [New treatment option for gram-positive infections in critically ill patients - overview over linezolid].
Krueger WA; Unertl KE
Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Apr; 37(4):199-204. PubMed ID: 11967745
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and Pharmacodynamics.
Rao GG; Konicki R; Cattaneo D; Alffenaar JW; Marriott DJE; Neely M;
Ther Drug Monit; 2020 Feb; 42(1):83-92. PubMed ID: 31652190
[TBL] [Abstract][Full Text] [Related]
14. Optimization of linezolid therapy in the critically ill: the effect of adjusted infusion regimens.
Taubert M; Zander J; Frechen S; Scharf C; Frey L; Vogeser M; Fuhr U; Zoller M
J Antimicrob Chemother; 2017 Aug; 72(8):2304-2310. PubMed ID: 28541510
[TBL] [Abstract][Full Text] [Related]
15. Plasma exposure of free linezolid and its ratio to minimum inhibitory concentration varies in critically ill patients.
Yagi T; Naito T; Doi M; Nagura O; Yamada T; Maekawa M; Sato S; Kawakami J
Int J Antimicrob Agents; 2013 Oct; 42(4):329-34. PubMed ID: 23988716
[TBL] [Abstract][Full Text] [Related]
16. How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy?
Jamal JA; Mueller BA; Choi GY; Lipman J; Roberts JA
Diagn Microbiol Infect Dis; 2015 May; 82(1):92-103. PubMed ID: 25698632
[TBL] [Abstract][Full Text] [Related]
17. Linezolid more efficacious than vancomycin to eradicate infecting organism in critically ill patients with Gram-positive infections.
Sirvent JM; Piñeiro L; de la Torre M; Motjé M; de Batlle J; Bonet A
Rev Esp Quimioter; 2010 Mar; 23(1):27-35. PubMed ID: 20232021
[TBL] [Abstract][Full Text] [Related]
18. Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.
Cepeda JA; Whitehouse T; Cooper B; Hails J; Jones K; Kwaku F; Taylor L; Hayman S; Shaw S; Kibbler C; Shulman R; Singer M; Wilson AP
J Antimicrob Chemother; 2004 Feb; 53(2):345-55. PubMed ID: 14711840
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of linezolid in critically ill patients on renal replacement therapy: comparison of equal doses in continuous venovenous haemofiltration and continuous venovenous haemodiafiltration.
Roger C; Muller L; Wallis SC; Louart B; Saissi G; Lipman J; Lefrant JY; Roberts JA
J Antimicrob Chemother; 2016 Feb; 71(2):464-70. PubMed ID: 26538503
[TBL] [Abstract][Full Text] [Related]
20. Decreased Linezolid Serum Concentrations in Three Critically Ill Patients: Clinical Case Studies of a Potential Drug Interaction between Linezolid and Rifampicin.
Blassmann U; Roehr AC; Frey OR; Koeberer A; Briegel J; Huge V; Vetter-Kerkhoff C
Pharmacology; 2016; 98(1-2):51-5. PubMed ID: 27046487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
